Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis

• Main Authors: Qian Xiang (Author), Mengxi Wang (Author), Yuhan Ding (Author), Manlu Fan (Author), Huaqin Tong (Author), Jiandong Chen (Author), Peng Yu (Author), Le Shen (Author), Xiaohu Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Heart failure with reduced ejection fraction (HFrEF) is a complex, chronic disease and is among the top causes of morbidity and mortality. Angiotensin receptor-neprilysin inhibitor drugs represented by sacubitril/valsartan are the key drugs for the treatment of HFrEF in western medicine,...